Telomir Pharmaceuticals (TELO) Earnings Date & Reports
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TELO is expected to report earnings to rise 166.67% to -7 cents per share on February 25
Q4'25
Est.
$-0.08
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.03
Q1'25
Missed
by $0.01
The last earnings report on December 03 showed earnings per share of -2 cents, beating the estimate of -3 cents. With 89.11K shares outstanding, the current market capitalization sits at 45.38M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TELO showed earnings on December 03, 2025. You can read more about the earnings report here.